Nikos Maniadakis

3.8k total citations
125 papers, 1.9k citations indexed

About

Nikos Maniadakis is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Nikos Maniadakis has authored 125 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Economics and Econometrics, 32 papers in Cardiology and Cardiovascular Medicine and 22 papers in Oncology. Recurrent topics in Nikos Maniadakis's work include Health Systems, Economic Evaluations, Quality of Life (48 papers), Pharmaceutical Economics and Policy (21 papers) and Blood Pressure and Hypertension Studies (10 papers). Nikos Maniadakis is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (48 papers), Pharmaceutical Economics and Policy (21 papers) and Blood Pressure and Hypertension Studies (10 papers). Nikos Maniadakis collaborates with scholars based in Greece, United States and United Kingdom. Nikos Maniadakis's co-authors include Georgia Kourlaba, Bruce Hollingsworth, P.J. Dawson, Stathis Kontodimas, Μάμας Θεοδώρου, George Gourzoulidis, M Aristides, Andreas Pavlakis, Alastair Gray and John Kyriopoulos and has published in prestigious journals such as SHILAP Revista de lepidopterología, Lara D. Veeken and BMC Health Services Research.

In The Last Decade

Nikos Maniadakis

121 papers receiving 1.8k citations

Peers

Nikos Maniadakis
Melissa A. Robb United States
Mitchell K. Higashi United States
Gérard de Pouvourville France
Rachel E. Sherman United States
A Bagust United Kingdom
Jaume Puig‐Junoy Spain
James M. O’Brien United States
Alexander Turchin United States
Dong‐Churl Suh United States
Edmund R. Becker United States
Melissa A. Robb United States
Nikos Maniadakis
Citations per year, relative to Nikos Maniadakis Nikos Maniadakis (= 1×) peers Melissa A. Robb

Countries citing papers authored by Nikos Maniadakis

Since Specialization
Citations

This map shows the geographic impact of Nikos Maniadakis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikos Maniadakis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikos Maniadakis more than expected).

Fields of papers citing papers by Nikos Maniadakis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikos Maniadakis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikos Maniadakis. The network helps show where Nikos Maniadakis may publish in the future.

Co-authorship network of co-authors of Nikos Maniadakis

This figure shows the co-authorship network connecting the top 25 collaborators of Nikos Maniadakis. A scholar is included among the top collaborators of Nikos Maniadakis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikos Maniadakis. Nikos Maniadakis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaló, Zoltán, et al.. (2021). Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives. Cost Effectiveness and Resource Allocation. 19(1). 42–42. 6 indexed citations
2.
Kourlaba, Georgia, et al.. (2020). Incidence and cost of bleeding events requiring hospitalization in patients with atrial fibrillation treated with acenocoumarol in Greece. Hellenic Journal of Cardiology. 62(3). 234–240. 1 indexed citations
3.
Brixner, Diana, et al.. (2018). An Evidence Framework for Off-Patent Pharmaceutical Review for Health Technology Assessment in Emerging Markets. Value in Health Regional Issues. 16. 9–13. 13 indexed citations
4.
5.
Gourzoulidis, George, Georgia Kourlaba, Dimitrios Petrakis, et al.. (2017). Economic Evaluation of Trifluridine and Tipiracil Hydrochloride in The Treatment of Metastatic Colorectal Cancer in Greece. Value in Health. 20(9). A434–A434. 1 indexed citations
6.
Kourlaba, Georgia, et al.. (2015). A Literature Review To Evaluate The Pharmacoeconomic Value Of Ranolazine For The Treatment Of Symptomatic Chronic Stable Angina. Value in Health. 18(7). A395–A395. 1 indexed citations
7.
Kourlaba, Georgia, Charalambos Vlachopoulos, John Parissis, et al.. (2015). Ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Greece: a cost-utility study. BMC Health Services Research. 15(1). 566–566. 6 indexed citations
8.
Kourlaba, Georgia, et al.. (2015). Cost-Utility of Ranibizumab Versus Aflibercept for Treating Visual Impairment Due to Diabetic Macular Edema In Greece. Value in Health. 18(7). A423–A423. 1 indexed citations
9.
10.
11.
12.
Maniadakis, Nikos, et al.. (2013). Economic evaluation of agomelatine relative to other antidepressants for treatment of major depressive disorders in Greece. BMC Health Services Research. 13(1). 173–173. 16 indexed citations
13.
Kourlaba, Georgia, Nikos Maniadakis, Athanasios Giannoukas, et al.. (2012). PCV54 Economic Evaluation of Rivaroxaban in the Treatment of Deep Vein Thrombosis in Greece. Value in Health. 15(7). A372–A372. 1 indexed citations
14.
Θεοδώρου, Μάμας, Δάφνη Καϊτελίδου, Petros Galanis, et al.. (2011). Quality of life measurement in patients with hypertension in Cyprus.. PubMed. 52(5). 407–15. 51 indexed citations
15.
Θεοδώρου, Μάμας, et al.. (2010). The public's and doctors' perceived role in participation in setting health care priorities in Greece.. PubMed. 51(3). 200–8. 8 indexed citations
16.
Maniadakis, Nikos, et al.. (2010). Developing HTA frameworks in emerging markets: the road ahead. The case of Greece.. 16(4). 11–14. 2 indexed citations
17.
Maniadakis, Nikos, et al.. (2008). Measuring intra-hospital clinic efficiency and productivity : an application to a Greek university general hospital. EUROPEAN RESEARCH STUDIES JOURNAL. 95–110. 11 indexed citations
18.
Prezerakos, Panagiotis, et al.. (2007). Measuring across hospital efficiency and productivity : the case of second regional health authority of Attica. EUROPEAN RESEARCH STUDIES JOURNAL. 83–96. 6 indexed citations
19.
Lees, Michael, et al.. (2003). Economic evaluation of gemcitabine in the treatment of pancreatic cancer in the UK. The European Journal of Health Economics. 4(3). 216–221. 12 indexed citations
20.
Hollingsworth, Bruce, Nikos Maniadakis, & Emmanuel Thanassoulis. (1999). Efficiency. Measured response.. PubMed. 109(5682). 28–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Melissa A. Robb Breakdown of academic impact, for papers by Mitchell K. Higashi Breakdown of academic impact, for papers by Gérard de Pouvourville Breakdown of academic impact, for papers by Rachel E. Sherman Breakdown of academic impact, for papers by A Bagust Breakdown of academic impact, for papers by Jaume Puig‐Junoy Breakdown of academic impact, for papers by James M. O’Brien Breakdown of academic impact, for papers by Alexander Turchin Breakdown of academic impact, for papers by Dong‐Churl Suh Breakdown of academic impact, for papers by Edmund R. Becker
Rankless by CCL
2026